Last reviewed · How we verify

an extract of Cimicifuga Foetida L.

Shandong Luye Pharmaceutical Co., Ltd. · FDA-approved active Small molecule

An herbal extract from Cimicifuga foetida that modulates estrogen-related pathways and inflammatory responses, traditionally used to manage menopausal symptoms.

An herbal extract from Cimicifuga foetida that modulates estrogen-related pathways and inflammatory responses, traditionally used to manage menopausal symptoms. Used for Menopausal symptoms (hot flashes, night sweats, mood disturbances).

At a glance

Generic namean extract of Cimicifuga Foetida L.
Also known asXimingting
SponsorShandong Luye Pharmaceutical Co., Ltd.
Drug classHerbal extract / phytoestrogen
ModalitySmall molecule
Therapeutic areaWomen's Health / Endocrinology
PhaseFDA-approved

Mechanism of action

Cimicifuga foetida (black cohosh relative) contains phytoestrogens and other bioactive compounds that may act as selective estrogen receptor modulators or modulate serotonergic and GABAergic pathways. The extract is believed to reduce vasomotor symptoms and mood disturbances associated with menopause through these multiple mechanisms rather than direct estrogen replacement.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results